The sad truth about rare diseases | Be Inspired

Having seen the investment banking and finance world from the inside as well as the pharmaceutical industry, James Harrison, Founder and Group CEO of Cycle Pharmaceuticals joins Julia Hoggett, CEO of the London Stock Exchange to discuss how CyclePharmaceuticals is improving the quality of life for patients with rare diseases around the world. James explains how their business model aims to provide life-long treatment to patients, how they are approaching acquisitions and measuring success, and how they are providing free medication to patients in the developing world.

#BeInspired

The UK Capital Markets Industry Taskforce (CMIT) comprises CEOs, Chairs and industry leaders representing private and publicly listed companies, asset owners and managers, and the advisory services that support their access to capital and investments. The Taskforce aims to maximise the impact of capital market reforms, ensuring the UK is the place where great companies can start, grow, scale and stay. Learn more about CMIT: https://capitalmarketsindustrytaskforce.com/

Check out more episodes of the Be Inspired CEO series: https://bit.ly/3vfpLlc

London Stock Exchange podcast

Spotify: https://spoti.fi/3Qb7UnP

Apple: https://apple.co/3zFz5l7

Google: https://bit.ly/3PP8GXC

Web: https://bit.ly/3SftpWo

RSS: https://bit.ly/3oHi9V2

source